Status:
COMPLETED
Longitudinal Studies of the Glycoproteinoses
Lead Sponsor:
Greenwood Genetic Center
Conditions:
Aspartylglucosaminuria
Fucosidosis
Eligibility:
All Genders
Brief Summary
The glycoproteinoses are among the most rare and least researched of the lysosomal diseases. The diseases include aspartylglucosaminuria, fucosidosis, galactosialidosis, alpha-mannosidosis, beta-manno...
Detailed Description
This is a longitudinal study of 100 individuals diagnosed with any one of the nine glycoproteinoses. Because of the small number of individuals diagnosed with these diseases, participants will be stro...
Eligibility Criteria
Inclusion
- Be an individual of any age diagnosed with one of the following conditions
- Aspartylglucosaminuria
- Fucosidosis
- Galactosialidosis
- alpha mannosidosis
- beta mannosidosis
- Mucolipidosis II
- Mucolipidosis III
- Schindler disease
- Sialidosis
Exclusion
- not diagnosed with one of the nine glycoproteinoses listed above.
Key Trial Info
Start Date :
August 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01891422
Start Date
August 1 2009
End Date
July 1 2020
Last Update
September 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Greenwood Genetic Center
North Charleston, South Carolina, United States, 29418